These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15350727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
    Bonvicini F, Gallinella G, Cricca M, Ambretti S, Delbarba S, Musiani M, Zerbini M.
    J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
    [Abstract] [Full Text] [Related]

  • 6. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
    Knöll A, Louwen F, Kochanowski B, Plentz A, Stüssel J, Beckenlehner K, Jilg W, Modrow S.
    J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
    [Abstract] [Full Text] [Related]

  • 7. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT.
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [Abstract] [Full Text] [Related]

  • 8. [Detection of B19 parvovirus in plasma pools before solvent-detergent treatment of plasma: AFSSAPS and EFS Aquitaine-Limousin's experience].
    Petermann R, Piquet Y, Lapeyre M, Goujon N, Gauthier M, Lalanne V, Mouillot L, Tissier MH, Boiron JM.
    Transfus Clin Biol; 2010 Apr; 17(2):54-62. PubMed ID: 20674438
    [Abstract] [Full Text] [Related]

  • 9. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates.
    Schalasta G, Schmid M, Lachmund T, Enders G.
    J Med Virol; 2004 May; 73(1):54-9. PubMed ID: 15042648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
    Baylis SA, Buchheit KH.
    Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory.
    Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M.
    J Med Virol; 2002 Jun; 67(2):275-81. PubMed ID: 11992590
    [Abstract] [Full Text] [Related]

  • 13. Use of digoxigenin-labelled probes for the detection of B19 parvovirus DNA in batches of blood products.
    Lefrère JJ, Mariotti M.
    Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):985-8. PubMed ID: 8595378
    [Abstract] [Full Text] [Related]

  • 14. Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination.
    Bonvicini F, Gallinella G, Gentilomi GA, Ambretti S, Musiani M, Zerbini M.
    Clin Lab; 2006 Nov; 52(5-6):263-8. PubMed ID: 16812953
    [Abstract] [Full Text] [Related]

  • 15. Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions.
    Compston LI, Sarkobie F, Li C, Candotti D, Opare-Sem O, Allain JP.
    J Virol Methods; 2008 Jul; 151(1):47-54. PubMed ID: 18479760
    [Abstract] [Full Text] [Related]

  • 16. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
    Pichl L, Heitmann A, Herzog P, Oster J, Smets H, Schottstedt V.
    Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
    [Abstract] [Full Text] [Related]

  • 17. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P, Siegl G, Michel BA, Brühlmann P.
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
    Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S.
    Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.
    Modrow S, Wenzel JJ, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W, Eis-Hübinger AM.
    Vox Sang; 2011 May; 100(4):351-8. PubMed ID: 21133933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.